A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting

ConclusionsCompared with INF-treated patients, pwMS on DMF and Teri reported the best treatment satisfaction, although DMF-treated pwMS reported higher side effects and those on Teri the worst QoL and fatigue; however, the older age, higher disability and depression, and worse cognitive performance of pwMS on Teri suggest to be careful in evaluating these results.
Source: Neurological Sciences - Category: Neurology Source Type: research